相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-dose cisplatin-induced CXCR4 expression promotes proliferation of ovarian cancer stem-like cells
Yifei Chen et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2016)
Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy
Hyun-Kyung Jung et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system
R. Chiaramonte et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
Giovanni Luca Gravina et al.
PROSTATE (2015)
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
Aaron Goldman et al.
NATURE COMMUNICATIONS (2015)
Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
Yan Gao et al.
ONCOTARGET (2015)
CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
Haixia Long et al.
ONCOTARGET (2015)
Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
Wenzhe Ma et al.
SCIENTIFIC REPORTS (2015)
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
Michele Cioffi et al.
SCIENTIFIC REPORTS (2015)
Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer
Jia Li et al.
BMB REPORTS (2014)
Anticancer Effects of Chemokine Receptor 4(CXCR4) Gene Silenced by CXCR4-siRNA in Nude Mice Model of Ovarian Cancer
Wei Liu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
The SDF-1/CXCR4 axis induces epithelial-mesenchymal transition in hepatocellular carcinoma
Xuqi Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Novel Role for NFAT3 in ERK-Mediated Regulation of CXCR4
Keven Huang et al.
PLOS ONE (2014)
Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells
Zhi-hua Yu et al.
TUMOR BIOLOGY (2014)
CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype
Kyu Sub Kang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer
Baoyao Xue et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis
Ai-Fang Huang et al.
MOLECULAR CANCER (2013)
Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy
Emma Salomonnson et al.
PLOS ONE (2013)
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
A. Popple et al.
BRITISH JOURNAL OF CANCER (2012)
SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
Xuqi Li et al.
CANCER LETTERS (2012)
CD44+/CD24-ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
Erhong Meng et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Eradication of chemotherapy-resistant CD44+human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin
Francesca Casagrande et al.
CANCER (2011)
Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
Lyndsay V. Rhodes et al.
CANCER RESEARCH (2011)
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi et al.
CANCER RESEARCH (2011)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12
Raphael Lis et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
Miranda P. Ween et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Identification of CD44 as a Surface Biomarker for Drug Resistance by Surface Proteome Signature Technology
Jason W. Cain et al.
MOLECULAR CANCER RESEARCH (2011)
Lymph Node Stromal Cells Enhance Drug-Resistant Colon Cancer Cell Tumor Formation through SDF-1α/CXCR4 Paracrine Signaling
David A. Margolin et al.
NEOPLASIA (2011)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line
M. F. Shi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
Ayesha B. Alvero et al.
CELL CYCLE (2009)
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Joseph Kwong et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
CXCR4 and CXCL12 down-regulation:: A novel mechanism for the chemoprotection of 3,3′-diindolylmethane for breast and ovarian cancers
Erin L. Hsu et al.
CANCER LETTERS (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Expression of CD133-1 and CD133-2 in ovarian cancer
G. Ferrandina et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Involvement of SDF-1 alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma
Hiroaki Kajiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity
Benedict Law et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
M Burger et al.
BLOOD (2005)
A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma
M Takenaga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells
JM Hall et al.
MOLECULAR ENDOCRINOLOGY (2003)
分享论文
